In vitro fertilization (IVF): why doing it in unstimulated cycles?;En fécondation in vitro (FIV) : pourquoi je ne stimule pas ?

Gynecologie Obstetrique et Fertilite

Volumn 35, Issue 9, 2007, Pages 877-880

  Basille, C ^a   Fay, S ^a   Hesters, L ^b   Frydman, N ^b   Frydman, R ^a,b  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b INSERM   (France)

Author keywords

Altered ovarian status (AOS); Assisted reproductive techniques (ART); Controlled ovarian hyperstimulation (COH); Implantation failure (IMF); In vitro fertilization (IVF)

Indexed keywords

ARTICLE; ENDOMETRIUM; FERTILIZATION IN VITRO; HUMAN; IMPLANTATION; OVARY HYPERSTIMULATION; PREGNANCY RATE; TREATMENT FAILURE; TREATMENT INDICATION;

EID: 34548601424     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2007.07.006     Document Type: Article

References (32)

1. Steptoe P.C., and Edwards R.G. Birth after the reimplantation of a human embryo. Lancet 12 2 (1978) 366
2. Land J.A., Yarmolinskaya M.I., Dumoulin J.C., and Evers J.L. High-dose human menopausal gonadotropin. Fertil. Steril. 65 (1996) 961-965
3. Karande V., Morris R., Rinehart J., Miller C., Rao R., and Gleicher N. Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization. Fertil. Steril. 67 5 (1997) 900-903
4. Moreno C., Ruiz A., Simon C., Pellicer A., and Remohi J. Intracytoplasmic sperm injection as a routine indication in low responder patients. Hum. Reprod. 13 8 (1998) 2126-2129
5. Keay S.D., Lenton E.A., Cooke I.D., Hull M.G., and Jenkins J.M. Low-dose dexamethasone augments the ovarian response to exogenous gonadotrophins leading to a reduction in cycle cancellation rate in a standard IVF programme. Hum. Reprod. 16 9 (2001) 1861-1865
6. Mitwally M.F., and Casper R.F. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil. Steril. 77 4 (2002) 776-780
7. Lok I.H., Yip S.K., Cheung L.P., Yin Leung P.H., and Haines C.J. Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial. Fertil. Steril. 81 3 (2004) 556-561
8. Daya S., Gunby J., Hughes E.G., Collins J.A., Sagle M.A., and YoungLai E.V. Natural cycles for in-vitro fertilization: cost-effectiveness analysis and factors influencing outcome. Hum. Reprod. 10 7 (1995) 1719-1724
9. Mendez Lozano D.H., Fanchin R., Chevalier N., Feyereisen E., Hesters L., Frydman N., and Frydman R. The follicular flushing duplicate the pregnancy rate on semi natural cycle IVFJ. Gynecol. Obstet. Biol. Reprod. (Paris) 36 1 (2007) 36-41
10. Bassil S., Godin P.A., and Donnez J. Outcome of in-vitro fertilization through natural cycles in poor responders. Hum. Reprod. 14 5 (1999) 1262-1265
11. Rongières-Bertrand C., Olivennes F., Righini C., Fanchin R., Taieb J., Hamamah S., et al. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation. Hum. Reprod. 14 3 (1999) 683-688
12. Janssens R.M., Lambalk C.B., Vermeiden J.P., Schats R., and Schoemaker J. In-vitro fertilization in a spontaneous cycle: easy, cheap and realistic. Hum. Reprod. 15 2 (2000) 314-318
13. Ubaldi F.M., Rienzi L., Ferrero S., Baroni E., Sapienza F., Cobellis L., et al. Management of poor responders in IVF. Reprod. Biomed. Online 10 2 (2005) 235-246 (Review)
14. Castelo Branco A., Achour-Frydman N., Kadoch J., Fanchin R., Tachdjian G., and Frydman R. In vitro fertilization and embryo transfer in seminatural cycles for patients with ovarian aging. Fertil. Steril. 84 4 (2005) 875-880
15. Pelinck M.J., Hoek A., Simons A.H., and Heineman M.J. Efficacy of natural cycle IVF: a review of the literature. Hum. Reprod. Update 8 2 (2002) 129-139 (Review)
16. Nargund G., Waterstone J., Bland J., Philips Z., Parsons J., and Campbell S. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles. Hum. Reprod. 16 2 (2001) 259-262
17. Morgia F., Sbracia M., Schimberni M., Giallonardo A., Piscitelli C., Giannini P., et al. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil. Steril. 81 6 (2004) 1542-1547
18. Fauser B.C., Devroey P., Yen S.S., Gosden R., Crowley Jr. W.F., and Baird D.T. Minimal ovarian stimulation for IVF: appraisal of potential benefit and drawbacks. Hum. Reprod. 14 (1999) 2681-2686
19. Baart E.B., Martini E., Eijkemans M.J., Van Opstal D., Beckers N.G., Verhoeff A., et al. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum. Reprod. 22 4 (2007) 980-988
20. Ziebe S., Bangsboll S., Schmidt K.L., Loft A., Lindhard A., and Nyboe Andersen A. Embryo quality in natural versus stimulated IVF cycles. Hum. Reprod. 19 6 (2004) 1457-1460
21. Basir G.S., O W.S., Ng E.H., and Ho P.C. Morphometric analysis of peri-implantation endometrium in patients having excessively high oestradiol concentrations after ovarian stimulation. Hum. Reprod. 16 3 (2001) 435-440
22. Devroey P., Bourgain C., Macklon N.S., and Fauser B.C. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol. Metab. 15 2 (2004) 84-90 (Review)
23. Kolb B.A., and Paulson R.J. The luteal phase of cycles utilizing controlled ovarian hyperstimulation and he possible impact of this hyperstimulation on embryo implantation. Am. J. Obstet. Gynecol. 176 6 (1997) 1262-1267
24. Macklon N.S., and Fauser B.C. Impact of ovarian hyperstimulation on the luteal phase. J. Reprod. Fertil. Suppl. 55 (2000) 101-108 (Review)
25. Tavaniotou A., Albano C., Smitz J., and Devroey P. Impact of ovarian stimulation on corpus luteum function and embryonic implantation. J. Reprod. Immunol. 55 1-2 (2002) 123-130 (Review)
26. Horcajadas J.A., Riesewijk A., Polman J., van Os R., Pellicer A., Mosselman S., et al. Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol. Hum. Reprod. 11 3 (2005) 195-205
27. Lédée-Bataille N., Dubanchet S., Kadoch J., Castelo-Branco A., Frydman R., and Chaouat G. Controlled natural in vitro fertilization may be an alternative for patients with repeated unexplained implantation failure and a high uterine natural killer cell count. Fertil. Steril. 82 1 (2004) 234-236
28. Pelinck M.J., Vogel N.E., Hoek A., Simons A.H., Arts E.G., Mochtar M.H., et al. Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: a multicentre cohort study. Hum. Reprod. 21 9 (2006) 2375-2383
29. Duckitt K., and Templeton A.A. Cancer in women with infertility. Curr. Opin. Obstet. Gynecol. 10 3 (1998) 199-203 (Review)
30. Lee S.J., Schover L.R., Partridge A.H., Patrizio P., Wallace W.H., Hagerty K., et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J. Clin. Oncol. 24 18 (2006) 2917-2931
31. Delvigne A., and Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum. Reprod. Update 8 6 (2002) 559-577 (Review)
32. Heijnen E.M., Eijkemans M.J., De Klerk C., Polinder S., Beckers N.G., Klinkert E.R., et al. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet 369 9563 (2007) 743-749